GALAPAGOS N.V. | 87.50 / -2.69% |
Date/Time | 01/28 / 12:44 |
Chg. / Chg.(%) | -2.42 / -2.69% |
Bid | 87.50 |
Ask | 87.70 |
Open | 89.92 |
Previous Close | 89.92 |
High | 89.92 |
Low | 86.62 |
Volume [EUR] | - |
Volume [Units] | |
Price fixings | 2548 |
ISIN | BE0003818359 |
Security | GXE |
Exchange | Lang & Schwarz |
Type | Stock |
Other Exchanges
Exchange | Last | Volume | |
---|---|---|---|
Euronext - A.. | 87.58 | ![]() |
157,836 |
Cboe Europe .. | 87.60 | ![]() |
23,516 |
London Inter.. | 87.72 | ![]() |
10,130 |
Turquoise | 87.54 | ![]() |
7,385 |
TradeGate | 87.58 | ![]() |
308 |
gettex | 87.600 | ![]() |
59 |
Frankfurt | 89.9200 | ![]() |
2 |
Cboe Europe .. | 87.70 | ![]() |
1 |
Düsseldorf | 87.92 | ![]() |
0 |
München | 90.20 | ![]() |
0 |
Berlin | 87.66 | ![]() |
0 |
Vienna Globa.. | 88.84 | ![]() |
0 |
Lang & Schwa.. | 87.50 | ![]() |
|
Stuttgart | 87.720 | ![]() |
|
Cboe Europe .. | 90.36 | 109 | |
Nasdaq Other.. | 110.1000 | ![]() |
58 |
Xetra | 90.60 | 15 |
News
- NICE recommends Jyseleca® ▼(filgotinib) on NHS in landmark decision for rheumatoid arthritis
01/21/2021 / 08:08 - GlobeNewswire - Oxurion NV appoints Prof Alan Stitt as Chief Scientific Officer
01/20/2021 / 08:00 - GlobeNewswire - Gilead holds 25.54% of Galapagos shares
01/11/2021 / 22:01 - GlobeNewswire - OXURION to Participate in Upcoming Investor Meetings
01/07/2021 / 08:00 - GlobeNewswire - Galapagos to present at 39th Annual J.P. Morgan Healthcare Conference
01/06/2021 / 15:30 - GlobeNewswire